Managed Account Advisors’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
$43.7M Buy
2,185,396
+649,604
+42% +$11.4M 0.04% 442
2015
Q1
$23.9M Sell
1,535,792
-47,832
-3% -$723K 0.02% 643
2014
Q4
$21.8M Buy
1,583,624
+344,124
+28% +$4.21M 0.02% 679
2014
Q3
$12.4M Buy
1,239,500
+612,824
+98% +$6.26M 0.01% 915
2014
Q2
$6.21M Buy
626,676
+142,980
+30% +$1.27M 0.01% 1259
2014
Q1
$5M Sell
483,696
-5,052
-1% -$52.2K 0.01% 1319
2013
Q4
$4.33M Buy
488,748
+65,196
+15% +$516K 0.01% 1365
2013
Q3
$2.99M Sell
423,552
-48,300
-10% -$306K ﹤0.01% 1498
2013
Q2
$2.65M Buy
+471,852
New +$2.26M ﹤0.01% 1507

Other funds holding DXCM

Managed Account Advisors's DXCM Position: Q2 2015 in Review

Managed Account Advisors increased its DexCom (DXCM) stake by 42% in Q2 2015, buying an estimated $11.4M and bringing the position to 2,185,396 shares worth $43.7M. The position accounts for 0.04% of the portfolio, ranked #442.

Managed Account Advisors first reported a position in DXCM in Q2 2013 and has held it in 9 quarters since. 258 funds tracked by Wall St. Rank hold DXCM as of Q2 2015.

  • Managed Account Advisors held 2,185,396 shares of DexCom worth $43.7M as of Q2 2015.
  • Managed Account Advisors bought 649,604 DexCom shares in Q2 2015, an estimated $11.4M.
  • DexCom made up 0.04% of Managed Account Advisors's portfolio in Q2 2015, its #442 holding.
  • Managed Account Advisors first reported a position in DexCom in Q2 2013 and has held it in 9 quarters since.
  • 258 funds tracked by Wall St. Rank held DexCom as of Q2 2015.

Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.